Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease

BACKGROUND: Anti-glomerular basement-membrane (anti-GBM) disease (or Goodpasture disease) is characterized by severe kidney and lung involvement. Prognoses have improved with treatments that combine plasma exchange and immunosuppressive drugs. However, patients with severe renal involvement can have...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitz, M., Carron, P. L., Clavarino, G., Jouve, T., Pinel, N., Guebre-Egziabher, F., Rostaing, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149204/
https://www.ncbi.nlm.nih.gov/pubmed/30236081
http://dx.doi.org/10.1186/s12882-018-1038-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149204/
https://www.ncbi.nlm.nih.gov/pubmed/30236081
http://dx.doi.org/10.1186/s12882-018-1038-7

Ejemplares similares